How EFPIA Set The Bar On Drug Safety Reporting During COVID-19
Executive Summary
Early disruptions caused by the coronavirus pandemic prompted the European pharmaceutical industry body, EFPIA, to establish a principles-based framework to help ensure consistency in managing compliance with pharmacovigilance responsibilities.